Detalles de la búsqueda
1.
Stereotactic body radiation therapy after radical prostatectomy: current status and future directions.
World J Urol;
41(11): 3333-3344, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725131
2.
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.
J Urol;
207(5): 1020-1028, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34978211
3.
The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients.
J Urol;
205(6): 1648-1654, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577365
4.
Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response.
World J Urol;
39(5): 1331-1343, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32915313
5.
Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer.
J Urol;
204(3): 416-426, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32096678
6.
Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.
J Urol;
203(6): 1109-1116, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31899651
7.
Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.
Prostate;
78(1): 64-75, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29134684
8.
177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice.
Curr Oncol;
31(3): 1400-1415, 2024 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534939
9.
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.
Can Urol Assoc J;
18(4): E127-E137, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381937
10.
Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen-Targeted 18 F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical Prostatectomy.
Clin Nucl Med;
48(4): e186-e187, 2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36630722
11.
Advances in PARP Inhibitors for Prostate Cancer.
Cancers (Basel);
15(6)2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980735
12.
Salvage Whole-Pelvic Radiation and Long-Term Androgen-Deprivation Therapy in the Management of High-Risk Prostate Cancer: Long-Term Update of the McGill 0913 Study.
Curr Oncol;
30(8): 7252-7262, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37623007
13.
Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects.
Cancers (Basel);
15(15)2023 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568655
14.
Neoadjuvant versus Concurrent Androgen Deprivation Therapy in Localized Prostate Cancer Treated with Radiotherapy: A Systematic Review of the Literature.
Cancers (Basel);
15(13)2023 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444473
15.
Prophylactic A-Blockers for Radiotherapy-Induced Lower Urinary Tract Symptoms in Men with Prostate Cancer: A Phase III Randomized Trial.
Cancers (Basel);
15(13)2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444553
16.
Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18 F PET/CT in prostate cancer patients in early biochemical failure.
Nucl Med Commun;
44(3): 187-193, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525002
17.
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada.
Prostate Cancer Prostatic Dis;
26(1): 74-79, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35197558
18.
The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer: A RADICAL-PC Analysis.
JACC CardioOncol;
5(1): 70-81, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36875906
19.
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.
Can Urol Assoc J;
17(10): 326-336, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37494316
20.
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer.
Eur Urol;
81(5): 437-439, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35065838